Maze Therapeutics, Inc. (MAZE) › Weighted Average Diluted SharesMaze Therapeutics, Inc. (MAZE): Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.42.98MYear ended 2025-12-312024-12-31: 2.73M2025-12-31: 42.98M42.98M2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3142.98Mn/m2026-03-25, From 2025-01-012024-12-312.73Mn/a2026-03-25, From 2024-01-01Other metrics: RevenueR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingEPS (Basic)